Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy.
With 45 pathologists and over half a million whole slide images (WSIs) produced annually, this network of London trusts deploys Aperio GT 450 DX scanners
In this blog post, you can learn about some of the new features in the 4.2 release, when to expect your chance to upgrade, and where to find user guides, release notes, and tutorial videos.
HALO®, HALO AI, and HALO Link 4.2 Features and Functionalities Read More »
HALO, HALO AI, and HALO Link 4.2 are now available! If you do not have an active SMS plan but would like to upgrade to
4.2 Upgrade request Read More »
The Clinical Trials module in HALO AP® and HALO AP Dx provides pathologists and researchers access to comprehensive digital pathology tools for building objective, unbiased datasets that support medical research and faster drug development.
Digital Pathology in Clinical Trials: Driving Faster Drug Development Read More »
21 October 2025 | Learn how HALO AP platforms are advancing anatomic pathology!
18 September 2025 | Learn about the exciting new features in the 4.2 versions of HALO, HALO AI, and HALO Link!
Intro to HALO®, HALO AI, and HALO Link 4.2 Read More »
16 October 2025 | Learn how to maximize the efficiency, customization, and data management capabilities of your HALO Link deployments!
Masterclass Webinar: Admin and Metadata Options in HALO Link Read More »
Check-out exciting new features and functionalities in the latest release of HALO AP®, AI-powered digital pathology platform for diagnostics
HALO AP® 2.4 Features and Functionalities Read More »
HALO AP® 2.4 is now available! Submit the form below to request your upgrade. How it works: Following submission of an upgrade request form, a
HALO AP 2.4 Upgrade form Read More »
